Transdermal composition of phosphatidylcholine and method for producing same
AssigneeMedrx Co., Ltd.
InventorsKeiko Yamasaki, Takahiro Tanimoto
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedrx Co., Ltd.
InventorsKeiko Yamasaki, Takahiro Tanimoto
Estimating the term…
Disclosed is a transdermal composition, which uses high-purity phosphatidylcholine that is most susceptible to oxidation and the like, and which exhibits high stability and high migration into the skin. Specifically, a transdermal composition having good stability and migration into the skin is able to be obtained by preparing a transdermal composition (a colloidal dispersion liquid of phosphatidylcholine) that contains high-purity phosphatidylcholine, carnitine, a polyhydric alcohol and water. Since the transdermal composition does not contain an oleaginous base (an oil component), the transdermal composition has skin compatibility and is thus useful as a therapeutic agent or a cosmetic preparation. In addition, phosphatidylcholine and carnitine have an effect of achieving good migration into the skin and are capable of promoting systemic or local lipid metabolism in subcutaneous adipose tissues. Consequently, the transdermal composition is able to provide a transdermal preparation that is capable of promoting lipolysis in subcutaneous adipose tissues.
A transdermal composition consisting of phosphatidylcholine derived from a natural product, L-carnitine, propylene glycol, glycerin, water, and optionally, one or more selected from the group consisting of a fragrance, an antioxidant, a preservative, a colorant, a buffer, a pH adjuster, an ultraviolet absorber, and an antimicrobial agent.
Dependencies are inferred from the claim text.